Chronic subdural haematoma in antithrombotic cohorts: characteristics, surgical outcomes, and recurrence

References

• Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017;28:205–10.
   PubMed Web of Science ®Google Scholar
• Sim YW, Min KS, Lee MS, et al. Recent changes in risk factors of chronic subdural hematoma. J Korean Neurosurg Soc 2012;52:234–9.
   PubMed Web of Science ®Google Scholar
• Gonugunta V, Buxton N. Warfarin and chronic subdural haematomas. Br J Neurosurg 2001;15:514–7.
   PubMed Web of Science ®Google Scholar
• Lindvall P, Koskinen L. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009;16:1287–90.
   PubMed Web of Science ®Google Scholar
• Vuk A, Stancić V, Rincić G, et al. Nontraumatic bilateral subdural hematoma caused by antiaggregation therapy: case report and review of the literature. Acta Clin Croat 2010;49:163–8.
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Schneck MJ, Biller J. Discontinuation of perioperative antiplatelet and anticoagulant therapy in stroke patients. Neurol Clin 2006;24:607–30.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–60.
   PubMed Web of Science ®Google Scholar
• Birkeland P, Lauritsen J, Poulsen FR. Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation. JNS 2015;123:423–6.
   PubMed Web of Science ®Google Scholar
• Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 2005;257:399–414.
   PubMed Web of Science ®Google Scholar
• Chen L, Dong L, She L, et al. Treatment of chronic subdural hematoma by novel YL-1 hollow needle aspiration drainage system (697 cases report). Neurol Sci 2017;38:109–13.
   PubMed Web of Science ®Google Scholar
• Markwalder TM. The course of chronic subdural hematomas after burr-hole craniostomy with and without closed-system drainage. Neurosurg Clin N Am 2000;11:541–6.
   PubMed Web of Science ®Google Scholar
• Park SH, Kang DH, Park J, et al. Fibrinogen and D-dimer analysis of chronic subdural hematomas and computed tomography findings: A prospective study. Clin Neurol Neurosurg 2011;113:272–6.
   PubMed Web of Science ®Google Scholar
• Miki K, Abe H, Morishita T, et al. Double-crescent sign as a predictor of chronic subdural hematoma recurrence following burr-hole surgery. J Neurosurg 2019;4:1–7.
   Google Scholar
• Baechli H, Nordmann A, Bucher HC, et al. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 2004;27:263–6.
   PubMed Web of Science ®Google Scholar
• Aspegren OP, Åstrand R, Lundgren MI, et al. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 2013;115:981–4.
   PubMed Web of Science ®Google Scholar
• Shim YS, Park CO, Hyun DK, et al. What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma? Yonsei Med J 2007;48:210–7.
   PubMed Web of Science ®Google Scholar
• Kalamatianos T, Stavrinou LC, Koutsarnakis C, et al. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. JNS 2013;118:353–7.
   PubMed Web of Science ®Google Scholar
• DeWald TA, Washam JB, Becker RC. Anticoagulants: pharmacokinetics, mechanisms of action, and indications. Neurosurg Clin N Am 2018;29:503–15.
   PubMed Web of Science ®Google Scholar
• Goldstein H, Sonabend AM, Connolly ES. Jr., Chronic subdural hematomas: perspective on current treatment paradigms. World Neurosurg 2012;78:66–8.
   PubMed Web of Science ®Google Scholar
• Ma YH, Fei Z. Management of chronic subdural haematoma. Lancet 2010;375:195–6.
   PubMedGoogle Scholar
• Tinyei I, Kocsi Z, Pénzes I, et al. Hemorrhagic complications of chronic anticoagulant treatment in a single intensive care unit. Orv Hetil 2013;154:1829–35.
   PubMed Web of Science ®Google Scholar
• Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012;35:155–69.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang M, Zheng H, et al. The effects of antithrombotic drugs on the recurrence and mortality in patients with chronic subdural hematoma: A meta-analysis. Medicine (Baltimore) 2019;98:e13972.
   PubMed Web of Science ®Google Scholar
• Munoz-Bendix C, Pannewitz R, Remmel D, et al. Outcome following surgical treatment of chronic subdural hematoma in the oldest-old population. Neurosurg Rev 2017;40:461–8.
   PubMedGoogle Scholar
• Fei X, Wan Y, Wang Z, et al. Application of YL-1 needle in chronic subdural hematoma treatment for super-aged patients. J Craniofac Surg 2018;29:e90–4.
   PubMed Web of Science ®Google Scholar
• Okano A, Oya S, Fujisawa N, et al. Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 2014;28:204–8.
   PubMed Web of Science ®Google Scholar
• Christopher E, on behalf of the British Neurosurgical Trainee Research Collaborative (BNTRC), Poon MTC, Glancz LJ, et al. Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma. Neurosurg Rev 2019;42:427–31.
   PubMed Web of Science ®Google Scholar
• Nathan S, Goodarzi Z, Jette N, et al. Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 2017;88:1889–93.
   PubMed Web of Science ®Google Scholar
• Tahsim-Oglou Y, Beseoglu K, Hänggi D, et al. Factors predicting recurrence of chronic subdural haematoma: the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir 2012;154:1063–8.
   PubMed Web of Science ®Google Scholar
• Ohba S, Kinoshita Y, Nakagawa T, et al. The risk factors for recurrence of chronic subdural hematoma. Neurosurg Rev 2013;36:145–50.
   PubMed Web of Science ®Google Scholar
• Burchell SR, Tang J, Zhang JH. Hematoma expansion following intracerebral hemorrhage: mechanisms targeting the coagulation cascade and platelet activation. Curr Drug Targets 2017;18:1329–44.
   PubMed Web of Science ®Google Scholar
• Chon KH, Lee JM, Koh EJ, et al. Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir 2012;154:1541–8.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Uchino K, Hasegawa Y. Characteristics of symptomatic intracranial hemorrhage in patients receiving non-vitamin K antagonist oral anticoagulant therapy. PLOS One 2015;10:e0132900.
   PubMed Web of Science ®Google Scholar